Geode Capital Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.07K | Sell |
|
|||||
|
2025
Q1 | $20.6K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $33.4K | Hold |
|
|||||
|
2024
Q1 | $66.2K | Hold |
|
|||||
|
2023
Q4 | $60.7K | Hold |
|
|||||
|
2023
Q3 | $76.2K | Buy |
|
|||||
|
2023
Q2 | $116K | Hold |
|
|||||
|
2023
Q1 | $81.2K | Hold |
|
|||||
|
2022
Q4 | $52K | Sell |
|
|||||
|
2022
Q3 | $114K | Hold |
|
|||||
|
2022
Q2 | $248K | Buy |
|
|||||
|
2022
Q1 | $321K | Buy |
|
|||||
|
2021
Q4 | $265K | Hold |
|
|||||
|
2021
Q3 | $448K | Buy |
|
|||||
|
2021
Q2 | $576K | Buy |
|
|||||
|
2021
Q1 | $586K | Buy |
|
|||||
|
2020
Q4 | $6K | Hold |
|
|||||
|
2020
Q3 | $8K | Hold |
|
|||||
|
2020
Q2 | $9K | Hold |
|
|||||
|
2020
Q1 | $5K | Hold |
|
|||||
|
2019
Q4 | $8K | Hold |
|
|||||
|
2019
Q3 | $8K | Hold |
|
|||||
|
2019
Q2 | $9K | Hold |
|
|||||
|
2019
Q1 | $11K | Hold |
|
|||||
|
2018
Q4 | $9K | Hold |
|
|||||
|
2018
Q3 | $45K | Hold |
|
|||||
|
2018
Q2 | $147K | Hold |
|
|||||
|
2018
Q1 | $196K | Hold |
|
|||||
|
2017
Q4 | $313K | Buy |
|
|||||
|
2017
Q3 | $474K | Buy |
|
|||||
|
2017
Q2 | $225K | Sell |
|
|||||
|
2017
Q1 | $347K | Buy |
|
|||||
|
2016
Q4 | $409K | Buy |
|
|||||
|
2016
Q3 | $850K | Buy |
|
|||||
|
2016
Q2 | $878K | Buy |
|
|||||
|
2016
Q1 | $942 | Buy |
|
|||||
|
2015
Q4 | $813K | Hold |
|
|||||
|
2015
Q3 | $806K | Buy |
|
|||||
|
2015
Q2 | $830K | Buy |
|
|||||
|
2015
Q1 | $553K | Hold |
|
|||||
|
2014
Q4 | $369K | Buy |
|
|||||
|
2014
Q3 | $309K | Buy |
|
|||||
|
2014
Q2 | $256K | Hold |
|
|||||
|
2014
Q1 | $383K | Buy |
|
|||||
|
2013
Q4 | $150K | Hold |
|
|||||
|
2013
Q3 | $165K | Hold |
|
|||||
|
2013
Q2 | $169K | Buy |
|